# Albemarle Corp: financial statements, quarterly

ALB · NYSE · CIK 915913 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alb.md) · [Financials](/companies/alb/financials.md) · [Filings](/companies/alb/filings.md) · [Insiders](/companies/alb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/alb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,311](/filings/0000915913-24-000158.md) | [2,356 d](/filings/0000915913-26-000018.md) | [1,361](/filings/0000915913-25-000084.md) | [1,430](/filings/0000915913-25-000133.md) | [1,355](/filings/0000915913-25-000162.md) | [1,232 d](/filings/0000915913-26-000018.md) | [1,077](/filings/0000915913-26-000072.md) | [1,330](/filings/0000915913-26-000102.md) | [1,308](/filings/0000915913-25-000162.md) | [1,428 d](/filings/0000915913-26-000018.md) | [1,429](/filings/0000915913-26-000072.md) | [1,743](/filings/0000915913-26-000102.md) |
| Cost of revenue | $m | [2,256](/filings/0000915913-24-000158.md) | [3,060 d](/filings/0000915913-26-000018.md) | [1,322](/filings/0000915913-25-000084.md) | [1,441](/filings/0000915913-25-000133.md) | [1,459](/filings/0000915913-25-000162.md) | [1,094 d](/filings/0000915913-26-000018.md) | [921](/filings/0000915913-26-000072.md) | [1,133](/filings/0000915913-26-000102.md) | [1,190](/filings/0000915913-25-000162.md) | [1,230 d](/filings/0000915913-26-000018.md) | [928](/filings/0000915913-26-000072.md) | [1,153](/filings/0000915913-26-000102.md) |
| Gross profit | $m | [54.9](/filings/0000915913-24-000158.md) | [(704) d](/filings/0000915913-26-000018.md) | [38.9](/filings/0000915913-25-000084.md) | [(10.6)](/filings/0000915913-25-000133.md) | [(104)](/filings/0000915913-25-000162.md) | [138 d](/filings/0000915913-26-000018.md) | [156](/filings/0000915913-26-000072.md) | [197](/filings/0000915913-26-000102.md) | [118](/filings/0000915913-25-000162.md) | [198 d](/filings/0000915913-26-000018.md) | [501](/filings/0000915913-26-000072.md) | [590](/filings/0000915913-26-000102.md) |
| Research and development | $m | [21.1](/filings/0000915913-24-000158.md) | [22.8 d](/filings/0000915913-26-000018.md) | [23.5](/filings/0000915913-25-000084.md) | [20.8](/filings/0000915913-25-000133.md) | [22.4](/filings/0000915913-25-000162.md) | [20.0 d](/filings/0000915913-26-000018.md) | [14.1](/filings/0000915913-26-000072.md) | [12.4](/filings/0000915913-26-000102.md) | [12.7](/filings/0000915913-25-000162.md) | [12.2 d](/filings/0000915913-26-000018.md) | [9.2](/filings/0000915913-26-000072.md) | [3.7](/filings/0000915913-26-000102.md) |
| Selling, general and administrative | $m | [172](/filings/0000915913-24-000158.md) | [194 d](/filings/0000915913-26-000018.md) | [161](/filings/0000915913-25-000084.md) | [166](/filings/0000915913-25-000133.md) | [154](/filings/0000915913-25-000162.md) | [136 d](/filings/0000915913-26-000018.md) | [124](/filings/0000915913-26-000072.md) | [132](/filings/0000915913-26-000102.md) | [139](/filings/0000915913-25-000162.md) | [156 d](/filings/0000915913-26-000018.md) | [137](/filings/0000915913-26-000072.md) | [126](/filings/0000915913-26-000102.md) |
| Operating income | $m | [(140)](/filings/0000915913-24-000158.md) | [(850) d](/filings/0000915913-26-000018.md) | [(180)](/filings/0000915913-25-000084.md) | [(493)](/filings/0000915913-25-000133.md) | [(1,109)](/filings/0000915913-25-000162.md) | [4.4 d](/filings/0000915913-26-000018.md) | [19.8](/filings/0000915913-26-000072.md) | [47.5](/filings/0000915913-26-000102.md) | [(217)](/filings/0000915913-25-000162.md) | [(217) d](/filings/0000915913-26-000018.md) | [234](/filings/0000915913-26-000072.md) | [453](/filings/0000915913-26-000102.md) |
| Income tax | $m | [(8.6)](/filings/0000915913-24-000158.md) | [119 d](/filings/0000915913-26-000018.md) | [(3.7)](/filings/0000915913-25-000084.md) | [(30.7)](/filings/0000915913-25-000133.md) | [111](/filings/0000915913-25-000162.md) | [10.6 d](/filings/0000915913-26-000018.md) | [(4.0)](/filings/0000915913-26-000072.md) | [34.1](/filings/0000915913-26-000102.md) | [(30.6)](/filings/0000915913-25-000162.md) | [157 d](/filings/0000915913-26-000018.md) | [21.5](/filings/0000915913-26-000072.md) | [94.0](/filings/0000915913-26-000102.md) |
| Net income | $m | [303](/filings/0000915913-24-000158.md) | [(618) d](/filings/0000915913-26-000018.md) | [2.4](/filings/0000915913-25-000084.md) | [(188)](/filings/0000915913-25-000133.md) | [(1,069)](/filings/0000915913-25-000162.md) | [75.3 d](/filings/0000915913-26-000018.md) | [41.3](/filings/0000915913-26-000072.md) | [22.9](/filings/0000915913-26-000102.md) | [(161)](/filings/0000915913-25-000162.md) | [(414) d](/filings/0000915913-26-000018.md) | [319](/filings/0000915913-26-000072.md) | [480](/filings/0000915913-26-000102.md) |
| Diluted EPS | $ per share | [2.57](/filings/0000915913-24-000158.md) | not reported | [(0.08)](/filings/0000915913-25-000084.md) | [(1.96)](/filings/0000915913-25-000133.md) | [(9.45)](/filings/0000915913-25-000162.md) | not reported | [0.00](/filings/0000915913-26-000072.md) | [(0.16)](/filings/0000915913-26-000102.md) | [(1.72)](/filings/0000915913-25-000162.md) | not reported | [2.34](/filings/0000915913-26-000072.md) | [3.52](/filings/0000915913-26-000102.md) |
| Basic EPS | $ per share | [2.58](/filings/0000915913-24-000158.md) | not reported | [(0.08)](/filings/0000915913-25-000084.md) | [(1.96)](/filings/0000915913-25-000133.md) | [(9.45)](/filings/0000915913-25-000162.md) | not reported | [0.00](/filings/0000915913-26-000072.md) | [(0.16)](/filings/0000915913-26-000102.md) | [(1.72)](/filings/0000915913-25-000162.md) | not reported | [2.35](/filings/0000915913-26-000072.md) | [3.72](/filings/0000915913-26-000102.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.6](/filings/0000915913-23-000180.md) | [0.9](/filings/0000915913-24-000158.md) | [2.1](/filings/0000915913-24-000100.md) | [1.8](/filings/0000915913-24-000139.md) | [1.7](/filings/0000915913-24-000158.md) | [1.2](/filings/0000915913-25-000162.md) | [1.5](/filings/0000915913-25-000084.md) | [1.8](/filings/0000915913-25-000133.md) | [1.9](/filings/0000915913-25-000162.md) | [1.6](/filings/0000915913-26-000102.md) | [1.1](/filings/0000915913-26-000072.md) | [1.6](/filings/0000915913-26-000102.md) |
| Current assets | $bn | [7.1](/filings/0000915913-23-000180.md) | [5.2](/filings/0000915913-25-000026.md) | [5.8](/filings/0000915913-24-000100.md) | [5.2](/filings/0000915913-24-000139.md) | [4.7](/filings/0000915913-24-000158.md) | [3.8](/filings/0000915913-26-000018.md) | [4.1](/filings/0000915913-25-000084.md) | [4.5](/filings/0000915913-25-000133.md) | [4.6](/filings/0000915913-25-000162.md) | [4.0](/filings/0000915913-26-000102.md) | [3.3](/filings/0000915913-26-000072.md) | [3.9](/filings/0000915913-26-000102.md) |
| Total assets | $bn | [18.9](/filings/0000915913-23-000180.md) | [18.3](/filings/0000915913-26-000018.md) | [19.0](/filings/0000915913-24-000100.md) | [18.4](/filings/0000915913-24-000139.md) | [17.5](/filings/0000915913-24-000158.md) | [16.6](/filings/0000915913-26-000018.md) | [17.0](/filings/0000915913-25-000084.md) | [17.3](/filings/0000915913-25-000133.md) | [17.1](/filings/0000915913-25-000162.md) | [16.4](/filings/0000915913-26-000102.md) | [15.1](/filings/0000915913-26-000072.md) | [15.9](/filings/0000915913-26-000102.md) |
| Current liabilities | $bn | [3.9](/filings/0000915913-23-000180.md) | [3.6](/filings/0000915913-25-000026.md) | [2.1](/filings/0000915913-24-000100.md) | [2.0](/filings/0000915913-24-000139.md) | [1.9](/filings/0000915913-24-000158.md) | [2.0](/filings/0000915913-26-000018.md) | [1.9](/filings/0000915913-25-000084.md) | [1.9](/filings/0000915913-25-000133.md) | [2.0](/filings/0000915913-25-000162.md) | [1.8](/filings/0000915913-26-000102.md) | [1.6](/filings/0000915913-26-000072.md) | [1.9](/filings/0000915913-26-000102.md) |
| Long-term debt | $bn | [3.5](/filings/0000915913-23-000180.md) | [3.5](/filings/0000915913-25-000026.md) | [3.5](/filings/0000915913-24-000100.md) | [3.5](/filings/0000915913-24-000139.md) | [3.6](/filings/0000915913-24-000158.md) | [3.1](/filings/0000915913-26-000018.md) | [3.1](/filings/0000915913-25-000084.md) | [3.2](/filings/0000915913-25-000133.md) | [3.2](/filings/0000915913-25-000162.md) | [3.1](/filings/0000915913-26-000102.md) | [1.8](/filings/0000915913-26-000072.md) | [1.8](/filings/0000915913-26-000102.md) |
| Current portion of debt | $bn | [0.2](/filings/0000915913-23-000180.md) | [0.6](/filings/0000915913-25-000026.md) | [0.0](/filings/0000915913-24-000100.md) | [0.0](/filings/0000915913-24-000139.md) | [0.0](/filings/0000915913-24-000158.md) | [0.4](/filings/0000915913-26-000018.md) | [0.4](/filings/0000915913-25-000084.md) | [0.4](/filings/0000915913-25-000133.md) | [0.4](/filings/0000915913-25-000162.md) | [0.1](/filings/0000915913-26-000102.md) | [0.1](/filings/0000915913-26-000072.md) | [0.1](/filings/0000915913-26-000102.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [9.9](/filings/0000915913-23-000180.md) | [9.4](/filings/0000915913-25-000026.md) | [11.5](/filings/0000915913-24-000100.md) | [11.2](/filings/0000915913-24-000139.md) | [10.2](/filings/0000915913-24-000158.md) | [10.0](/filings/0000915913-26-000018.md) | [10.0](/filings/0000915913-25-000084.md) | [10.2](/filings/0000915913-25-000133.md) | [10.0](/filings/0000915913-25-000162.md) | [9.5](/filings/0000915913-26-000102.md) | [9.9](/filings/0000915913-26-000072.md) | [10.3](/filings/0000915913-26-000102.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [629 d](/filings/0000915913-24-000158.md) | [(97.0) d](/filings/0000915913-26-000018.md) | [97.5](/filings/0000915913-25-000133.md) | [368 d](/filings/0000915913-25-000133.md) | [227 d](/filings/0000915913-25-000162.md) | [(4.4) d](/filings/0000915913-26-000018.md) | [547](/filings/0000915913-26-000072.md) | [(9.0) d](/filings/0000915913-26-000102.md) | [356 d](/filings/0000915913-25-000162.md) | [388 d](/filings/0000915913-26-000018.md) | [346](/filings/0000915913-26-000072.md) | [710 d](/filings/0000915913-26-000102.md) |
| Capital expenditure | $m | [546 d](/filings/0000915913-24-000158.md) | [689 d](/filings/0000915913-26-000018.md) | [583](/filings/0000915913-25-000133.md) | [452 d](/filings/0000915913-25-000133.md) | [303 d](/filings/0000915913-25-000162.md) | [343 d](/filings/0000915913-26-000018.md) | [183](/filings/0000915913-26-000072.md) | [120 d](/filings/0000915913-26-000102.md) | [132 d](/filings/0000915913-25-000162.md) | [155 d](/filings/0000915913-26-000018.md) | [98.7](/filings/0000915913-26-000072.md) | [71.7 d](/filings/0000915913-26-000102.md) |
| Dividends paid | $m | [46.9 d](/filings/0000915913-24-000158.md) | [46.9 d](/filings/0000915913-26-000018.md) | [46.9](/filings/0000915913-25-000084.md) | [47.0 d](/filings/0000915913-25-000133.md) | [47.0 d](/filings/0000915913-25-000162.md) | [47.6 d](/filings/0000915913-26-000018.md) | [47.6](/filings/0000915913-26-000072.md) | [47.6 d](/filings/0000915913-26-000102.md) | [47.7 d](/filings/0000915913-25-000162.md) | [47.6 d](/filings/0000915913-26-000018.md) | [47.7](/filings/0000915913-26-000072.md) | [47.7 d](/filings/0000915913-26-000102.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [118](/filings/0000915913-23-000180.md) | [118](/filings/0000915913-24-000100.md) | [118](/filings/0000915913-24-000139.md) | [118](/filings/0000915913-24-000158.md) | [117](/filings/0000915913-25-000084.md) | [118](/filings/0000915913-25-000133.md) | [118](/filings/0000915913-25-000162.md) | [118](/filings/0000915913-26-000072.md) | [118](/filings/0000915913-26-000102.md) | [118](/filings/0000915913-25-000162.md) | [119](/filings/0000915913-26-000072.md) | [136](/filings/0000915913-26-000102.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 118,005,057 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0000915913-26-000102.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.